Showing results (1-10 of 200) with videos related to
Sort By:
Pageof 20
BMC Cancer|June 30, 2023
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancerJulia Foldi, Anastasia Tsagianni, Max Salganik, et al.Seminars in Oncology|May 30, 2006
Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST updateAdam BrufskyExperimental Hematology & Oncology|March 28, 2017
nab-Paclitaxel for the treatment of breast cancer: an update across treatment settingsAdam BrufskyJournal of Medical Virology|April 16, 2020
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemicAdam BrufskyAmerican Journal of Clinical Oncology|August 14, 2009
Trastuzumab-based therapy for patients with HER2-positive breast cancer: from early scientific development to foundation of careAdam BrufskyFrontiers in Medicine|January 31, 2024
Case report: abemaciclib-induced syndrome of inappropriate antidiuretic hormone (SIADH) without underlying kidney injury in a patient with early-stage estrogen receptor (ER)+ breast cancerNeil Carleton, Julia FoldiHematology/Oncology Clinics of North America|August 7, 2013
How to develop and deliver pathway-based careAdam Brufsky, Kathleen LokayInternational Journal of Cancer|May 15, 2014
Bisphosphonates in breast cancerAju Mathew, Adam BrufskyThe Breast Journal|December 27, 2019
Adjuvant bisphosphonate therapy in early-stage breast cancer-Treating the soil to kill the seedAdam Brufsky, Aju MathewFuture Oncology (London, England)|February 15, 2020
Neratinib: the emergence of a new player in the management of HER2+ breast cancer brain metastasisAzadeh Nasrazadani, Adam BrufskyPageof 20